Celldex Therapeutics to Present at 3rd Annual Evercore ISI HealthCONx Conference
November 30 2020 - 4:01PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that the
Company will participate in a fireside chat at the 3rd Annual
Evercore ISI HealthCONx Conference on Wednesday, December 2 at 4:20
pm ET.
A webcast of the presentation will be available on the "Events
& Presentations" page of the "Investors & Media" section of
the Celldex website. A replay will be available for fourteen days
following the event.
About Celldex Therapeutics, Inc.Celldex is a
clinical stage biotechnology company dedicated to developing
monoclonal and bispecific antibodies that address devastating
diseases for which available treatments are inadequate. Our
pipeline includes antibody-based therapeutics which have the
ability to engage the human immune system and/or directly affect
critical pathways to improve the lives of patients with
inflammatory diseases and many forms of cancer. Visit
www.celldex.com.
Company ContactSarah CavanaughSenior Vice
President, Corporate Affairs & AdministrationCelldex
Therapeutics, Inc.(781) 433-3161scavanaugh@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024